4th Quarter - Report

HOLLAND & KNIGHT LLP for ASHLAND INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive tax reform; global competitiveness for U.S. businesses; extending R&D tax credits; CFC look-through provision; duty suspension.

LobbyistCovered position, as disclosed
KERRY FEEHERY —
RICHARD M GOLD —
KATHRYN H LEHMAN —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

FDA over the counter drug approval process.

LobbyistCovered position, as disclosed
JOEL ROBERSON —
MICHAEL WERNER —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.